Current Management of HCV Genotype 3 Infection

Hepatitis C virus (HCV) genotype 3 (HCV-G3) is one of the seven recognized genotypes [1]. HCV-G3 is the second most common genotype accounting for 22% of all infections globally [2, 3]. Although three-quarters of them occur in South Asia, where it is endemic, the 3a subtype is an “epidemic subtype” widely distributed geographically, probably associated with injecting drug use [4].